Synchron Inc News Today

The research agreement aims to allow paralyzed patients to communicate and use mobile devices.

Synchrons investors include billionaires Jeff Bezos and Bill Gates

Synchron's BCI registry, a rival to Neuralink, facilitates trials for brain implant technology enthusiasts.

It plans to launch an online registry for patients interested in joining the process

Synchron Inc, a rival to Elon Musks Neuralink brain implant startup, is preparing to recruit patients for a large-scale clinical trial required to seek commercial approval for its device, the...

Synchron Inc, a rival to Elon Musk's Neuralink brain implant startup, is preparing to recruit patients for a large-scale clinical trial required to seek commercial approval for its device, the company's chief executive told Reuters. Synchron on Monday plans to launch an online registry for patients interested in joining the trial meant to include dozens of participants, and has received interest from about 120 clinical trial centers to help run the study, CEO Thomas Oxley said in an i...

The company is now analyzing U.S. data to prepare for the upcoming trial while awaiting a green light from the U.S. Food and Drug Administration.

Synchron plans to launch an online registry for patients interested in joining the trial

Synchron Inc, a rival to Elon Musk's Neuralink brain implant startup, is preparing to

/PRNewswire/ -- The "Brain Implants Global Market Report 2024" has been added to ResearchAndMarkets.coms offering. The brain implants market size has grown...